Botulinum Toxin in Treatments for Abnormal Movements
DOI:
https://doi.org/10.47606/ACVEN/MV0235Palabras clave:
botulinum toxin, movement disorders, parkinson's diseaseResumen
Introduction: Botulinum toxin is crucial for reducing sequelae in movement disorders such as Parkinson's. It blocks muscle contractions and improves quality of life, being used in both aesthetic and medical treatments. Methodology: A non-experimental longitudinal design was adopted, observing variables at multiple time points without manipulation. A mixed approach (qualitative and quantitative) was used with adults over 30 years old without Parkinson's history. The review included documents from PubMed, Scopus, and Scielo, applying rigorous inclusion and exclusion criteria. Objective: To evaluate the efficacy of botulinum toxin in treating abnormal movements in Parkinson's and understand its long-term effects. Results: Botulinum toxin type A reduces tremors by blocking acetylcholine. It improves motor symptoms of Parkinson's and essential tremor but requires frequent and costly treatments. There is a risk of developing antibodies that decrease its effectiveness. Discussion: It offers significant benefits, but its high cost and the need for frequent treatments are challenges. Patients report satisfaction in short-term studies, but more long-term research is needed. Conclusions: Promising for movement disorders, especially Parkinson's, although limited by cost and duration of effect. Future research should seek to extend therapeutic effects and reduce costs.
Descargas
Citas
Tater P, Pandey S. Botulinum toxin in movement disorders. Neurol India.
Cardoso F. Botulinum toxin in parkinsonism: The when, how, and which for botulinum toxin injections. Toxicon. 1 de junio de 2018. DOI: https://doi.org/10.1016/j.toxicon.2017.08.018
Bruno V, Freitas ME, Mancini D, Lui JP, Miyasaki J, Fox SH. Botulinum Toxin Type A for Pain in Advanced Parkinson’s Disease. Can J Neurol Sci. enero de 2018. DOI: https://doi.org/10.1017/cjn.2017.245
Naeem F, Reid J, Bailey M, Reid A, Smyth C, Taylor-Rowan M, et al Pharmacological Interventions for Sialorrhoea in People with Parkinson’s Disease: A Systematic Review and Meta-Analysis. Mov Disord Clin Pract. abril de 2023. DOI: https://doi.org/10.1002/mdc3.13688
Abusrair AH, Elsekaily W, Bohlega S. Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies. Tremor Other Hyperkinet Mov (N Y).
Jabbari B, Comtesse SM. Botulinum Toxin Treatment of Motor Disorders in Parkinson Disease-A Systematic Review. Toxins (Basel). 17 de enero de 2023. DOI: https://doi.org/10.3390/toxins15020081
Liao YH, Hong CT, Huang TW. Botulinum Toxin for Essential Tremor and Hands Tremor in the Neurological Diseases: A Meta Analysis of Randomized Controlled Trials. Toxins (Basel). 10 de marzo de 2022. DOI: https://doi.org/10.3390/toxins14030203
Anandan C, Jankovic J. Botulinum Toxin in Movement Disorders: An Update. Toxins. enero de 2021. DOI: https://doi.org/10.3390/toxins13010042
Tyslerowicz M, Kiedrzynska W, Adamkiewicz B, Jost WH, Slawek J. Cervical dystonia improving the effectiveness of botulinum toxin therapy. Neurologia i Neurochirurgia Polska. 2020. DOI: https://doi.org/10.5603/PJNNS.a2020.0021
Rueda Acevedo M, Fuquen FC. Disfunción autonómica en la enfermedad de Parkinson: enfoque práctico. Acta Neurológica Colombiana. 1 de septiembre de 2019. DOI: https://doi.org/10.22379/24224022252
Yildiz BT Berktas DT. Experiences on the administration of botulinum toxin in movement disorders Journal of Translational Internal Medicine. 1 de marzo de 2021.
Aplicacao de toxina botulínica no tratamento da sialorreia cronica em pacientes com doenças neurológicas [Internet]. PubSaúde. 2022 [citado 3 de junio de 2024]. Disponible en: https://pubsaude.com.br/revista/aplicacao-de-toxina-botulinica-no-tratamento-da-sialorreia-cronica-em-pacientes-com-doencas-neurologicas/
Li S, Francisco GE. The Use of Botulinum Toxin for Treatment of Spasticity. En: Whitcup SM, Hallett M, editores. Botulinum Toxin Therapy [Internet]. Cham: Springer International Publishing; 2021 [citado 3 de junio de 2024]. Disponible en: https://doi.org/10.1007/164_2019_315 DOI: https://doi.org/10.1007/164_2019_315
Hok P, Veverka T, Hluštík P, Nevrly M, Kanovský P. The Central Effects of Botulinum Toxin in Dystonia and Spasticity. Toxins. febrero de 2021. DOI: https://doi.org/10.3390/toxins13020155
Mojica YMR, García LCM, Ruíz DMC. Aplicación de toxina botulínica en el tratamiento de la distonía. Experiencia en un hospital de tercer nivel. Revista Colombiana de Medicina Física y Rehabilitación. 29 de junio de 2022.
Wissel J, Kivi A. Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection. Ann Rehabil Med. octubre de 2023. DOI: https://doi.org/10.5535/arm.23108
Fernández García G. TOXINA BOTULÍNICA Y SUS APLICACIONES CLÍNICAS. TOXINA BOTULÍNICA Y SUS APLICACIONES CLÍNICAS. 27 de abril de 2022.
Berardelli A, Conte A. The Use of Botulinum Toxin for Treatment of the Dystonias. En: Whitcup SM, Hallett M, editores. Botulinum Toxin Therapy [Internet]. Cham: Springer International Publishing; 2021 [citado 3 de junio de 2024]. Disponible en: https://doi.org/10.1007/164_2019_339 DOI: https://doi.org/10.1007/164_2019_339
Tambasco N, Filidei M, Nigro P, Parnetti L, Simoni S. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies. Toxins. diciembre de 2021. DOI: https://doi.org/10.3390/toxins13120881
de Jongh FW, Schaeffers AWMA, Kooreman ZE, Ingels KJAO, van Heerbeek N, Beurskens C, et al. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 1 de abril de 2023. DOI: https://doi.org/10.1007/s00405-022-07796-8
Hassell TJW, Charles D. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins. Toxins. abril de 2020. DOI: https://doi.org/10.3390/toxins12040269
Zakin E, Simpson DM. Botulinum Toxin Therapy in Writers Cramp and Musicians Dystonia. Toxins. diciembre de 2021. DOI: https://doi.org/10.3390/toxins13120899
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 María Gabriela González Chico, Xaviera Elizabeth Medina Godoy, Miliana Esperanza Estupiñan Bazurto, María José López Becerra
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.